Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NeuroVive in-licenses a genetic mitochondrial disease clinical stage project from Yungjin Pharm

pharmaasiaMay 17, 2017

Tag: Yungjin Pharm , genetic mitochondrial disease

PharmaSources Customer Service